epigallocatechin gallate has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, YW; Pang, QQ; Sheng, J; Wang, XJ; Yang, XY; Yu, CJ; Zhang, XJ; Zhu, QQ | 1 |
| Chen, J; Du, L; Li, J; Song, H | 1 |
2 other study(ies) available for epigallocatechin gallate and Chronic Kidney Diseases
| Article | Year |
|---|---|
EGCG targeting Notch to attenuate renal fibrosis
Topics: Animals; Antioxidants; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Injections, Intraperitoneal; Mice; Mice, Inbred ICR; Random Allocation; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta | 2020 |
Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis.
Topics: Animals; Antioxidants; Blotting, Western; Cadmium; Catechin; Fibrosis; Immunoenzyme Techniques; Male; Oxidative Stress; Rats; Rats, Wistar; Renal Insufficiency, Chronic | 2016 |